ContraFect
CFRX
$0.05000
Share price
-27.95%
Change (1 day)
-97.77%
Change (1 year)
Categories
ContraFect (CFRX) - Cash on Hand
Cash on Hand as of September 2023 : $5.41 M
According to ContraFect's latest financial reports the company has $5.41 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ContraFect - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $13.68 M | -74.8% |
| 2021-12-31 | $54.28 M | 27.76% |
| 2020-12-31 | $42.49 M | 75.69% |
| 2019-12-31 | $24.18 M | -20.58% |
| 2018-12-31 | $30.45 M | -35.01% |
| 2017-12-31 | $46.85 M | 33.25% |
| 2016-12-31 | $35.16 M | 6.8% |
| 2015-12-31 | $32.92 M | 20.18% |
| 2014-12-31 | $27.39 M | 560.83% |
| 2013-12-31 | $4.14 M | -47.44% |
| 2012-12-31 | $7.88 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $0.96 B | 17,690.06% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Prometheus Biosciences RXDX | $0.71 B | 13,084.37% | 🇺🇸 USA |